Free cash flow increased 85% year-over-year to $47.5 million. Operating cash flow was up 78% year-over-year.
"Our clinical workflow tools saw record use last quarter, including our telehealth platform, which served 375,000 unique active clinicians," said Jeff Tangney, co-founder and CEO at Doximity.
Doximity sees fourth-quarter revenue between $109.6 million and $110.6 million versus estimates of $123.08 million. The company lowered its full-year revenue outlook to a range of $417.7 million to $418.7 million versus estimates of $427.14 million.
See Also: Why Cloudflare Stock Is Rising After Hours
DOCS Price Action: Doximity has a 52-week high of $64.95 and a 52-week low of $22.91.
The stock was down 8.79% after hours at $33.20 at the time of writing, according to Benzinga Pro.
Photo: courtesy of Doximity.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
